Configurational assignment of 5β-cholestane-3α, 7α, 12α, 23, 25-pentol excreted by patients with cerebrotendinous xanthomatosis (a circular dichroism study)
- 1 March 1979
- Vol. 33 (3) , 327-338
- https://doi.org/10.1016/0039-128x(79)90009-6
Abstract
No abstract availableKeywords
Funding Information
- U.S. Public Health Service (AM-18707, HL-17818, AM-19696)
This publication has 13 references indexed in Scilit:
- Identification of (23S)-5β-cholestane-3α,7α,12α,23,25-pentol in cerebrotendinous xanthomatosis1,2Steroids, 1976
- A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat.Journal of Clinical Investigation, 1976
- Synthesis of 5β-cholestane-3α, 7α, 12α, 25-tetrol and 5β-cholestane-3α, 7α, 12α, 24ξ, 25-pentolJournal of Lipid Research, 1976
- Bile alcohol metabolism in man. Conversion of 5beta-cholestane-3alpha, 7alpha,12alpha, 25-tetrol to cholic acid.Journal of Clinical Investigation, 1975
- Identification of pentahydroxy bile alcohols in cerebrotendinous xanthomatosis: characterization of 5β-cholestane-3α, 7α, 12α, 24xi, 25-pentol and 5β-cholestane-3α, 7α, 12α, 23xi, 25-pentolJournal of Lipid Research, 1975
- A Biochemical Abnormality in Cerebrotendinous Xanthomatosis IMPAIRMENT OF BILE ACID BIOSYNTHESIS ASSOCIATED WITH INCOMPLETE DEGRADATION OF THE CHOLESTEROL SIDE CHAINJournal of Clinical Investigation, 1974
- The Metabolism of Cholestanol, Cholesterol, and Bile Acids in Cerebrotendinous XanthomatosisJournal of Clinical Investigation, 1973
- Oxidation of 5β‐Cholestane‐3α, 7α, 12α‐triol by Rat Liver MicrosomesEuropean Journal of Biochemistry, 1970